Rubicon Research Ltd
₹960.95
(0.49%)
Wed, 27 May 2026, 05:51 pm
Health Technology
Biotechnology
24.5KRubicon Research Share Price Live Chart
1 Day
(0.49%)
No Result Found
Summary
Market Cap
16102.70
Net Profit
134.36
P/B
0
Sector P/E
34.32
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.81
ROCE (Industry)
16.40
RONW (Industry)
14.39
ROE
29.02
ROCE
25.02
Debt/Equity
0.91
EPS (TTM)
12.52
Dividend Yield
0
Book Value
69.66
Interest Cover
6.29
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 |
|---|---|---|---|
| Promoters | 59.86 | 59.99 | 59.99 |
| FII | 7.54 | 7.99 | 9.37 |
| DII | 10.02 | 9.45 | 10.54 |
| Public | 22.58 | 22.57 | 20.10 |
| Government | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1346.70 | 1125.95 | 1047.95 | 905.20 | 827.20 | 684.45 | 463.70 |
| Fibonacci | 1125.95 | 1041.62 | 989.53 | 905.20 | 820.87 | 768.78 | 684.45 |
| Camarilla | 1030.66 | 1010.42 | 990.19 | 905.20 | 949.71 | 929.48 | 909.24 |
Pivots Level: Classic
R3
+441.50
1346.70
R2
+220.75
1125.95
R1
+142.75
1047.95
S1
-78.00
827.20
S2
-220.75
684.45
S3
-441.50
463.70
Moving Average
Period
Value
10-EMA
965.18
20-EMA
953.67
30-EMA
935.33
50-EMA
898.39
100-EMA
824.27
200-EMA
-
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 03 Feb 2026 | board-meetings | Quarterly Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results |
Peer Comparison
Rubicon Research Ltd
Dr Reddys Laboratories Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Cipla Ltd
Rubicon Research Ltd About
Rubicon Research is engaged in the business of developing, licensing acquiring, distributing, repacking, buying, selling, trading (whether domestically or outside), manufacturing or getting manufactured pharmaceutical products (prescribed and over the counter), whether patented and non-patented, fast moving consumer goods, consumer healthcare and prophylactic, wellness and hygiene, healthcare technology and data analytics and buying, selling, acquiring, building a brand of product categories as authorized under its memorandum of association.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1999
Headquarters
CEO
CHANGAVALLI VENKAT
Employees
Contact
Website
http://www.rubicon.co.in
investors@rubicon.co.in
Phone
022 6141 4000
Location
Medone House B-75 Road No.33, Wagle Estate, Thane (West), Maharashtra, 400604